checkAd

     113  0 Kommentare Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio at Digestive Disease Week 2024

    Regulatory News:

    Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the presentation of 9 abstracts supporting Cellvizio at the Digestive Disease Week (DDW) Conference, being held on May 18-21, 2024 in Washington, DC. These abstracts focus on artificial intelligence, pancreatic cystic lesions and pancreatic cancer, food intolerance and other gastrointestinal disorders. Studies and presentations are focused on how the use of Cellvizio positively impacts patient management and outcomes.

    Members of the Mauna Kea executive team will be present at DDW and meeting with physicians, industry partners, and societies, and welcome the opportunity to discuss the Company’s recent achievements and future opportunities as announced in the recent FY 2023 & Q1 2024 sales press release.

    "Each year, DDW brings the entire gastroenterology healthcare community together, and we are proud to have such a wide range of independent scientific abstracts and data about Cellvizio on display, especially in the rapidly developing field of artificial intelligence,” said Sacha Loiseau, Ph.D., Chairman and Chief Executive Officer of Mauna Kea Technologies. “Cellvizio's role in the classification and risk stratification of pancreatic cysts advances the outlook for the management of patients at risk of pancreatic cancer. Moreover, our clinical value in food intolerance identification and management is maturing quickly, setting up the next big opportunity for Cellvizio.”

    Highlighted featured presentations:

    ARTIFICIAL INTELLIGENCE-ASSISTED AUTOMATED PREDICTION OF ADVANCED NEOPLASIA IN IPMNS: A FUNCTIONAL MODEL
    Sunday, May 19, 10:32am-10:39am
    Session 3290
    Presenting author: Dr. Erica Park, The Ohio State University Wexner Medical Center

    CONFOCAL LASER ENDOMICROSCOPY WITH FOOD ALLERGY SENSITIVITY TESTING TO DETECT ATYPICAL FOOD ALLERGIES IN PEDIATRIC PATIENTS WITH CHRONIC ABDOMINAL PAIN AND IRRITABLE BOWEL SYNDROME
    Tuesday, May 21, 8:11am-8:18am
    Session 5145
    Presenting author: Dr. Clifton Huang, Cook Children’s Health Care System

    ACCURACY OF REAL-TIME EUS-GUIDED CONFOCAL LASER ENDOMICROSCOPY INTERPRETATION FOR DISCERNING SPECIFIC TYPES OF PANCREATIC CYSTIC LESIONS: INSIGHTS FROM A MULTICENTER PROSPECTIVE STUDY
    Tuesday, May 21, 10:15am-10:30am
    Session 5260
    Presenting author: Dr. Jordan Burlen, The Ohio State University Wexner Medical Center

    Featured poster sessions:

    Seite 1 von 4



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio at Digestive Disease Week 2024 Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the presentation of 9 abstracts supporting …

    Schreibe Deinen Kommentar

    Disclaimer